Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure.
Rubio-Gracia J, Demissei BG, Ter Maaten JM, Cleland JG, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Davison BA, Givertz MM, Bloomfield DM, Dittrich H, Damman K, Pérez-Calvo JI, Voors AA. Rubio-Gracia J, et al. Int J Cardiol. 2018 May 1;258:185-191. doi: 10.1016/j.ijcard.2018.01.067. Int J Cardiol. 2018. PMID: 29544928 Free article. Clinical Trial.
Surrogate end points in heart failure trials.
Gheorghiade M, Adams KF Jr, Gattis WA, Teerlink JR, Orlandi C, O'Connor CM. Gheorghiade M, et al. Am Heart J. 2003 Feb;145(2 Suppl):S67-70. doi: 10.1067/mhj.2003.159. Am Heart J. 2003. PMID: 12594457 No abstract available.
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4).
O'Connor CM, Gattis WA, Adams KF Jr, Hasselblad V, Chandler B, Frey A, Kobrin I, Rainisio M, Shah MR, Teerlink J, Gheorghiade M; Randomized Intravenous TeZosentan Study-4 Investigators. O'Connor CM, et al. J Am Coll Cardiol. 2003 May 7;41(9):1452-7. doi: 10.1016/s0735-1097(03)00194-3. J Am Coll Cardiol. 2003. PMID: 12742280 Free article. Clinical Trial.
Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M; IMPACT-HF Investigators and Coordinators. Gattis WA, et al. J Am Coll Cardiol. 2004 May 5;43(9):1534-41. doi: 10.1016/j.jacc.2003.12.040. J Am Coll Cardiol. 2004. PMID: 15120808 Free article. Clinical Trial.
1,115 results